These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 2946323)
1. The peptide beta 43-47 which increases microvascular permeability is released by plasmin during cleavage of fragment Y of fibrinogen. Cierniewski CS; Poniatowski J; Urbanczyk J Biochim Biophys Acta; 1986 Dec; 884(3):594-7. PubMed ID: 2946323 [TBL] [Abstract][Full Text] [Related]
2. Calcium modulates plasmin cleavage of the fibrinogen D fragment gamma chain N-terminus: mapping of monoclonal antibody J88B to a plasmin sensitive domain of the gamma chain. Odrljin TM; Rybarczyk BJ; Francis CW; Lawrence SO; Hamaguchi M; Simpson-Haidaris PJ Biochim Biophys Acta; 1996 Nov; 1298(1):69-77. PubMed ID: 8948490 [TBL] [Abstract][Full Text] [Related]
3. Characterization of an apparently lower molecular weight gamma-chain variant in fibrinogen Kyoto I. The replacement of gamma-asparagine 308 by lysine which causes accelerated cleavage of fragment D1 by plasmin and the generation of a new plasmin cleavage site. Yoshida N; Terukina S; Okuma M; Moroi M; Aoki N; Matsuda M J Biol Chem; 1988 Sep; 263(27):13848-56. PubMed ID: 2971046 [TBL] [Abstract][Full Text] [Related]
4. Generation of forms of fragment E with differing thrombin-binding properties during digestion of fibrinogen by plasmin. Goodwin CA; Kakkar VV; Scully MF Biochem J; 1992 Feb; 281 ( Pt 3)(Pt 3):613-8. PubMed ID: 1531588 [TBL] [Abstract][Full Text] [Related]
5. [Action of proteolytic enzymes on fibrinogen]. Jamet M; Levy G Ann Anesthesiol Fr; 1978; 19(8):687-91. PubMed ID: 31111 [TBL] [Abstract][Full Text] [Related]
6. Development of a radioimmunoassay for the fibrinogen-derived peptide B beta 1-42. Weitz JI; Koehn JA; Canfield RE; Landman SL; Friedman R Blood; 1986 Apr; 67(4):1014-22. PubMed ID: 2937467 [TBL] [Abstract][Full Text] [Related]
7. Immunologic identification of the cleavage products from the A alpha- and B beta-chains in the early stages of plasmin digestion of fibrinogen. Liu CY; Sobel JH; Weitz JI; Kaplan KL; Nossel HL Thromb Haemost; 1986 Aug; 56(1):100-6. PubMed ID: 2946092 [TBL] [Abstract][Full Text] [Related]
9. Sequence of plasmin proteolysis at the NH2-terminus of the b beta-chain of human fibrinogen. Koehn JA; Hurlet-Jensen A; Nossel HL; Canfield RE Anal Biochem; 1983 Sep; 133(2):502-10. PubMed ID: 6227262 [TBL] [Abstract][Full Text] [Related]
10. Anticoagulant and calcium-binding properties of high molecular weight derivatives of human fibrinogen (plasmin fragments Y). Nieuwenhuizen W; Voskuilen M; Hermans J Biochim Biophys Acta; 1982 Nov; 708(3):313-6. PubMed ID: 6216917 [TBL] [Abstract][Full Text] [Related]
11. Conformational and structural modulation of the NH2-terminal regions of fibrinogen and fibrin associated with plasmin cleavage. Edgington TS; Plow EF J Biol Chem; 1975 May; 250(9):3393-8. PubMed ID: 47328 [TBL] [Abstract][Full Text] [Related]
12. Immune responses to the cleavage-associated neoantigens of fibrinogen in man. Identification and characterization of humoral antibodies specific for cleavage fragments. Plow EF; Edgington TS J Clin Invest; 1975 Dec; 56(6):1509-18. PubMed ID: 53241 [TBL] [Abstract][Full Text] [Related]
13. Quantitation of fragment X formation during thrombolytic therapy with streptokinase and tissue plasminogen activator. Owen J; Friedman KD; Grossman BA; Wilkins C; Berke AD; Powers ER J Clin Invest; 1987 Jun; 79(6):1642-7. PubMed ID: 2953761 [TBL] [Abstract][Full Text] [Related]
14. Monocytic cell adhesion to intact and plasmin-modified fibrinogen: possible involvement of Mac-1 (CD11b/CD18) and ICAM-1 (CD54). Arefieva TL; Krasnikova TL J Cell Physiol; 2001 Sep; 188(3):403-9. PubMed ID: 11473367 [TBL] [Abstract][Full Text] [Related]
15. Degradation of cross-linked fibrin by matrix metalloproteinase 3 (stromelysin 1): hydrolysis of the gamma Gly 404-Ala 405 peptide bond. Bini A; Itoh Y; Kudryk BJ; Nagase H Biochemistry; 1996 Oct; 35(40):13056-63. PubMed ID: 8855941 [TBL] [Abstract][Full Text] [Related]
16. Binding phenomena of isolated unique plasmic degradation products of human cross-linked fibrin. Olexa SA; Budzynski AZ J Biol Chem; 1979 Jun; 254(11):4925-32. PubMed ID: 155698 [TBL] [Abstract][Full Text] [Related]
17. The monoclonal antibody that recognizes an epitope in the C-terminal region of the fibrinogen alpha-chain reacts with soluble fibrin and fibrin monomer generated by thrombin but not with those formed as plasmin degradation products. Suzuki A; Ebinuma H; Matsuo M; Miyazaki O; Yago H Thromb Res; 2007; 121(3):377-85. PubMed ID: 17561232 [TBL] [Abstract][Full Text] [Related]
18. [Fibrinogen fragment D - inhibitor of fibrinolytic processes]. Rozenfel'd MA; Fateeva LA; Gontar' ID Biokhimiia; 1983 Jul; 48(7):1135-40. PubMed ID: 6225469 [TBL] [Abstract][Full Text] [Related]
19. Immunochemical mapping of the conformation of human fibrinogen. The gamma 95-264 segment in inaccessible to antibody in native fibrinogen but progressively exposed by plasmic cleavage. Fair DS; Edgington TS; Plow EF J Biol Chem; 1981 Aug; 256(15):8018-23. PubMed ID: 6167572 [TBL] [Abstract][Full Text] [Related]
20. Permeability enhancing and chemotactic activities of lower molecular weight degradation products of human fibrinogen. Sueishi K; Nanno S; Tanaka K Thromb Haemost; 1981 Feb; 45(1):90-4. PubMed ID: 7245130 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]